Studies in mice suggest that the KIT D816V allele is a driver mutation in these cancers since expression of KITD816V, or the analogous mutation in mice (KITD814V), within hematopoietic stem cells (HSCs) leads to myeloproliferative disease (MPD) in mice [7, 8]. This evidence concerns the gene KIT and myeloproliferative disorder.